The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.
作者信息
BISHOP C, RAND R, TALBOTT J H
出版信息
J Clin Invest. 1951 Aug;30(8):889-95. doi: 10.1172/JCI102505.
Abstract
摘要
相似文献
1
The effect of benemid (P-[DI-N-propylsulfamyl]-benzoic acid) on uric acid metabolism in one normal and one gouty subject.
J Clin Invest. 1951 Aug;30(8):889-95. doi: 10.1172/JCI102505.
2
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
J Clin Invest. 1952 Jul;31(7):692-701. doi: 10.1172/JCI102651.
3
Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis.
Trans Assoc Am Physicians. 1951;64:279-88.
4
The influence of p-(di-n-propylsulfamyl)-benzoic acid on the excretion of uric acid.
U S Armed Forces Med J. 1952 Aug;3(8):1219-24.
5
The effect of benemid [p-(di-n-propylsulfamyl)benzoic acid] on blood levels of PAS.
J Lab Clin Med. 1951 Aug;38(2):227-33.
6
Benemid, p-(DI-n-propylsulfamyl)-benzoic acid; toxicologic properties.
J Pharmacol Exp Ther. 1951 Jul;102(3):208-14.
7
The effect of the prolonged administration of p-(di-n-propylsulfamyl)-benzoic acid (benemid) upon plasma concentrations of para-aminosalicylic acid.
Am Rev Tuberc. 1951 Oct;64(4):454-60.
8
Influence of p-(di-n-propylsulfamyl)-benzoic acid, "benemid", on para-aminosalicylic acid (PAS) plasma concentrations.
Am Rev Tuberc. 1950 Jun;61(6):862-7.
9
'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.
Am J Physiol. 1951 Sep;166(3):625-40. doi: 10.1152/ajplegacy.1951.166.3.625.
10
Effects of p.(di-n-propylsulfamyl) benzoic acid (benemid) on free and total sulfonamide plasma levels.
J Lab Clin Med. 1952 Nov;40(5):730-5.
引用本文的文献
1
The Treatment of Gout-1967.
J R Coll Physicians Lond. 1967 Jul;1(4):427-441.
2
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.
Clin Pharmacokinet. 2008;47(2):111-8. doi: 10.2165/00003088-200847020-00004.
3
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
J Clin Invest. 1952 Jul;31(7):692-701. doi: 10.1172/JCI102651.
4
Uric acid metabolism in psoriasis.
J Clin Invest. 1961 Aug;40(8 Pt 1-2):1486-94. doi: 10.1172/JCI104379.
5
Physiopathology, clinical manifestations, & treatment of gout. 2. Clinical & therapeutic studies.
Ann Rheum Dis. 1958 Mar;17(1):15-22. doi: 10.1136/ard.17.1.15.
6
Evaluation of uricosuric agents in chronic gout.
Ann Rheum Dis. 1957 Dec;16(4):425-37. doi: 10.1136/ard.16.4.425.
7
The effect of phenylbutazone on uric acid metabolism in two normal subjects.
J Clin Invest. 1955 Feb;34(2):256-62. doi: 10.1172/JCI103078.
8
[Effect of p-(dibutylsulfamoyl)-benzoic acid on water and sodium chloride excretion in diabetes insipidus].
Klin Wochenschr. 1954 Sep 1;32(33-34):783-90. doi: 10.1007/BF01477606.
9
Sodium salicylate and probenecid in the treatment of chronic gout; assessment of their relative effects in lowering serum uric acid levels.
Ann Rheum Dis. 1954 Sep;13(3):233-45. doi: 10.1136/ard.13.3.233.
10
[Uric acid excretion after longacid administration in normal and in gouty persons].
Klin Wochenschr. 1954 Jun 15;32(23-24):564-5. doi: 10.1007/BF01484942.
本文引用的文献
1
The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid.
J Biol Chem. 1949 Nov;181(1):183-93.
2
Pool size, turnover rate, and rapidity of equilibration of injected isotopic uric acid in normal and pathological subjects.
J Clin Invest. 1951 Aug;30(8):879-88. doi: 10.1172/JCI102504.
Zotero 插件